Shota Uehara

8PUBLICATIONS
31CO-AUTHORS
Nanoelectromechanical systemsBiologically active moleculesPharmacogenomicsNanomedicineBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 15, 2026
Structure-Based Drug Discovery of Non-SAM-Mimetic Bisubstrate Inhibitors against Nicotinamide N‑Methyltransferase.

Shuhei Yoshida, Noriyasu Kondo, Shota Uehara

|Jul 05, 2025
Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19.

Yuto Unoh, Keiichiro Hirai, Shota Uehara

|Feb 16, 2023
A Quantum Mechanics-Based Method to Predict Intramolecular Hydrogen Bond Formation Reflecting P-glycoprotein Recognition.

Takuya Oguma, Shota Uehara, Kenji Nakahara

|Aug 29, 2022
Identification of cap-dependent endonuclease inhibitors with broad-spectrum activity against bunyaviruses.

Shinsuke Toba, Akihiko Sato, Makoto Kawai

|Jul 29, 2022
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides.

Shuhei Yoshida, Shota Uehara, Noriyasu Kondo

|Mar 30, 2022
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.

Yuto Unoh, Shota Uehara, Kenji Nakahara

Pageof 2